CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM

本申请的目的是寻求多方面的支持， 学科临床肿瘤学研究培训计划。的 乔治城大学隆巴迪癌症中心（NCI指定 综合癌症中心）是一个独特的培训资源 所有临床和研究学科的学术医生 与癌症护理有关。该提案描述了一种结构， 支持临床医生在以下领域的研究培训： 转化肿瘤学研究一个合作和全面的 研究培训计划是描述之间的主要 临床肿瘤学学科（内科肿瘤学，外科肿瘤学， 妇科肿瘤学和放射医学）和相关的 研究学科（临床试验和转化基础 科学）。还概述了一个机制，以确定，选择和培训 肿瘤生物学、人类肿瘤学、肿瘤生物 肿瘤学、临床试验设计和 research.培训计划还将提供一个深入的 与适当的教师导师一起进行研究培训的经验 从临床或基础科学部门中挑选。 该计划将由主任领导 隆巴迪癌症中心和肿瘤内科主任 奖学金计划。咨询委员会将监督 研究候选人的选择和评估，包括 主要肿瘤学科的高级领导， 乔治敦大学以及生物统计学主任， 癌症预防和控制副主任，主任 发展治疗学的副主任和基础 科学最后，一组教师的教师已经 确定支持该计划，所有这些都取得了成功 在转化肿瘤学研究以及培训新的 investigators.

The purpose of this application is to seek support of a multi- disciplinary Clinical Oncology Research Training Program. The Lombardi Cancer Center of Georgetown University (an NCI designated Comprehensive Cancer Center) is a unique resource for training academic physicians in all clinical and research disciplines associated with cancer care. This proposal describes a structure to support the research training of clinicians in areas of translational oncology research. A collaborative and comprehensive research training program is described between the principal clinical oncology disciplines( Medical Oncology, Surgical Oncology, Gynecologic Oncology, and Radiation Medicine) and the associated research disciplines (clinical trials and translational basic science). A mechanism is also outlined to identify, select and train promising clinical candidates in core areas of tumor biology, human oncology, clinical trials design and the ethical conduct of research. The training program will also provide an in-depth research training experience with an appropriate faculty mentor selected from either the clinical or basic science departments. Leadership for the program will be provided by the director of the Lombardi Cancer Center and the Director of the Medical Oncology fellowship program. The Advisory Board, which will supervise the selection and evaluation of the research candidates, comprises the senior leadership of the major oncology disciplines within Georgetown University as well as the Director of Biostatistics, the Associate Director for Cancer prevention and Control, the Director of Developmental Therapeutics and the Associate Director of Basic Science. Finally, a group of faculty of faculty preceptors has been identified to support this program, all with demonstrated success in translational oncology research as well as the training of new investigators.